Sean McGowan on What’s in Store for Biosimilars in 2021 and Beyond

December 6, 2020

Sean McGowan, senior director of Biosimilars at AmerisourceBergen, discusses how 2020 has affected biosimilar development and his predictions for the industry going forward.

Sean McGowan, senior director of Biosimilars at AmerisourceBergen, recently appeared during a series of interviews on MJH Life Sciences™’ Medical World News about the challenges of bringing a biosimilar to market, how to ensure biosimilar competition in the future, and what to keep an eye on as the market grows over time. Today, we are bringing you the first part of that discussion, which focuses on McGowan’s thoughts on how 2020 has shaped biosimilar progress and his main predictions for the future of the biosimilars industry.

To watch the full first part of this interview, click here.

To watch part 2 of this interview, click here.

To watch part 3 of this interview, click here.

Related Content:

Podcasts